I-1-CC1-1@•ºŒÉŒ§—§¬l•aƒZƒ“ƒ^[®Œ`ŠO‰È
f’f ®Œ` •a— ‘Œv ”ä—¦
Intra vascular papillary endothelial hyperplasia@*(IPEH) 13 11 24 45%
Angiosarcoma 6 8 14 26%
Hemangioendothelioma 4 2 6 11%
Haemangioma 4   4 8%
Aneurysms with organized thrombus 1   1 2%
Extraskeletal osteosarcoma 1   1 2%
Gumma 1   1 2%
Hemangio pericytoma 1   1 2%
Inflammatory myxohyaline tumor 1   1 2%


I-1-CC1-2@_“ސ쌧—§‚ª‚ñƒZƒ“ƒ^[•a—
f’f ®Œ` •a— ‘Œv ”ä—¦
MPNST (*Malignant Peripheral Nerve Sheath Tumor) 11 4 15 28%
Extraskeletal osteosarcoma 5 4 9 17%
Ossifying fibromyxoid tumor 6 3 9 17%
Malignant ossifying fibromyxiod sarcoma 1 5 6 11%
Liposarcoma 3   3 6%
Clear cell sarcoma 1 1 2 4%
Extraskeletal chondrosarcoma 1 1 2 4%
Malignant mesenchymoma 2   2 4%
Epithelioid hemangioendothelioma   1 1 2%
FDG3 1   1 2%
Fibromyxoid sarcoma   1 1 2%
Malignant mixed tumor   1 1 2%
Osteoblastoma 1   1 2%


I-1-CC1-3@“Œ–M‘åŠw²‘q•a‰@•a—
f’f ®Œ` •a— ‘Œv ”ä—¦
Angiosarcoma 19 13 32 60%
MFH 2 1 3 6%
Epithelioid sarcoma 2   2 4%
Leiomyosarcoma 2   2 4%
Malignant melanoma 1 1 2 4%
Metastatic carcinoma 1 1 2 4%
Undifferentiated pleomorphic sarcoma   2 2 4%
Epithelioid malignant tumor 1   1 2%
Extraskeletal osteosarcoma 1   1 2%
Hemangio pericytoma 1   1 2%
Liposarcoma 1   1 2%
Mesenchymal chondrosarcoma 1   1 2%
Pleomorphic sarcoma   1 1 2%
Poorly differentiated malignant neoplasm, not otherwise specified (NOS)   1 1 2%
Solitary fibrous tumor (malignant)   1 1 2%


I-6-PCC1-1@ŠàŒ¤‹†‰ï•a‰@•a—
f’f ®Œ` •a— ‘Œv ”ä—¦
Malignant GCT 12 7 19 36%
Malignant fibrous histiocytoma (MFC) 10 8 18 34%
Giant cell tumor (*GCT) 7 2 9 17%
Osteosarcoma 2 3 5 9%
Atypical fibrous histiocytoma   1 1 2%
Xanthogranuloma 1   1 2%


I-6-PCC1-2@—®‹…‘åŠw®Œ`ŠO‰È
f’f ®Œ` •a— ‘Œv ”ä—¦
Adamantinoma 9 6 15 28%
Osteosarcoma 7 3 10 19%
Metastatic squamous cell carcinoma 5 2 7 13%
Mixed tumor 2 1 3 6%
Chondrosarcoma 2   2 4%
Fibrogranulation tissue (inadequate slide?) 2   2 4%
Atypical cell present   1 1 2%
Desmoplastic fibroma 1   1 2%
Epithelial cell nests in granulation tissue   1 1 2%
Granulation tissue 1   1 2%
Histiocytosis X   1 1 2%
Malignant bone tumor 1   1 2%
No diagnosis 2 6 8 15%


I-6-PCC1-4@ŠâŽèˆã‰È‘åŠw•a—Šw‘æ‚QuÀ
f’f ®Œ` •a— ‘Œv ”ä—¦
1) Osteosarcoma (Chondroblastic:1, Fibroblastic:1) 13 8 21 40%
2) Osteosarcoma (low grade) 1 3 4 8%
Osteoblastoma 5   5 9%
Solid type ABC 1 3 4 8%
Fibrous dysplasia 3   3 6%
Giant cell reparative granuloma 1 2 3 6%
Clear cell Chondrosarcoma 2   2 4%
Ossifying fibroma 1 1 2 4%
Aneurysmal Bone Cyst 1   1 2%
Chondroblastoma 1   1 2%
FDG3 1   1 2%
Metastatic squamous cell carcinoma   1 1 2%
Myofibroma with metaplastic bone formation? 1   1 2%
Myofibromatosis 1   1 2%
Myxoid MFH   1 1 2%
Ossifying fibromyxoid tumor   1 1 2%
Osteoid osteoma   1 1 2%


I-6-PCC1-5@‚’mˆã‰È‘åŠw®Œ`ŠO‰È
f’f ®Œ` •a— ‘Œv ”ä—¦
Osteosarcoma 24 16 40 74%
Osteoblastoma@(aggressive 9,@malignant 1) 9 5 14 26%


II-1-CC2-1@_ŒË‘åŠwˆãŠw•”®Œ`ŠO‰È
f’f ®Œ` •a— ‘Œv ”ä—¦
MFH 11 7 18 34%
Leiomyosarcoma 6 2 8 15%
MPNST (*Malignant peripheral Nerve Sheath Tumor) 4 2 6 11%
Rhabdomyosarcoma   5 5 9%
Fibrosarcoma 3 1 4 8%
Myxofibrosarcoma 2 1 3 6%
Liposarcoma (dedifferentiated type) 1 1 2 4%
Osteosarcoma 2   2 4%
Undifferentiated sarcoma 2   2 4%
Chondrosarcoma 1   1 2%
Low grade fibromyxoid sarcoma   1 1 2%
Synovial sarcoma 1   1 2%


II-1-CC2-2@“Œ–k‘åŠwˆãŠw•”®Œ`ŠO‰È
f’f ®Œ` •a— ‘Œv ”ä—¦
Liposarcoma 6 6 12 21%
Hemangiopericytoma 5 3 8 15%
MPNST (*Malignant peripheral Nerve Sheath Tumor) 4 2 6 11%
Solitary fibrous tumor@(malignant 2) 2 3 5 10%
Clear cell sarcoma 3 1 4 8%
Synovial sarcoma 2 1 3 6%
Hemangioendothelioma 1 1 2 4%
Rhabdomyosarcoma 2   2 4%
Askin tumor 1   1 2%
Epithelioid sarcoma 1   1 2%
Fibrosarcoma   1 1 2%
Follicular dendritic cell sarcoma   1 1 2%
Leiomyosarcoma 1   1 2%
Malignant lymphoma 1   1 2%
Malignant schwannoma   1 1 2%
Myopericytoma   1 1 2%
Osteosarcoma 1   1 2%
Sarcoma 1   1 2%


II-6-PCC2-1@ˆ®ìˆã‰È‘åŠw®Œ`ŠO‰È
f’f ®Œ` •a— ‘Œv ”ä—¦
Eosinophilic granuloma 9 9 18 35%
ABC 6 1 7 13%
PVNS 4 3 7 13%
Giant cell reparative granuloma 2 2 4 8%
Osteomyelitis 2 2 4 8%
Giant cell reaction 2 1 3 6%
Granulation tissue 2 1 3 6%
Osteosarcoma 2 1 3 6%
Chondroblastoma 1   1 2%
GCT 1   1 2%
Parasite infection 1   1 2%
No diagnosis   1 1 2%


II-6-PCC2-2@ˆ¤•Q‘åŠwˆãŠw•”•a—
f’f ®Œ` •a— ‘Œv ”ä—¦
Lipoma 10 5 15 28%
Osteochondroma 9 2 11 21%
Benign mesenchymoma 3 5 8 15%
Ectopic bone 2 3 5 9%
BPOP (Nora's lesion) 2 1 3 6%
Chondrosarcoma 1 1 2 4%
Miositis Ossificans 1 1 2 4%
Bursitis   1 1 2%
Hematoma 1   1 2%
Osteochondritis dissecans 1   1 2%
Reparative process   1 1 2%
No diagnosis 1 1 2 4%


II-6-PCC2-3@’é‹ž‘åŠwˆãŠw•”®Œ`ŠO‰È
f’f ®Œ` •a— ‘Œv ”ä—¦
Parachordoma 6 6 12 22%
Chondrosarcoma 3 5 8 15%
MPNST 5 3 8 15%
Clear cell sarcoma 4 2 6 11%
Metastatic cancer 2 1 3 6%
Rhabdomyosarcoma 2 1 3 6%
Alveolar soft part sarcoma 2   2 4%
PNET 2   2 4%
Synovial sarcoma 1 1 2 4%
Chordoid sarcoma   1 1 2%
Epithelioid sarcoma 1   1 2%
Malignant mesothelioma 1   1 2%
Malignant mixed tumor   1 1 2%
Parachordoma, malignant 1   1 2%
Rhabdoid timor 1   1 2%
No diagnosis 2   2 4%


II-6-PCC2-4@—Ս`•a‰@®Œ`ŠO‰È
f’f ®Œ` •a— ‘Œv ”ä—¦
MFH 20 13 33 62%
Myxofibrosarcoma   3 3 6%
BFH 1 1 2 4%
Leiomyosarcoma 2   2 4%
Liposarcoma 1 1 2 4%
Nodular fascitis 2   2 4%
Angiosarcoma 1   1 2%
DFSP   1 1 2%
Deap fibrous histiocytoma   1 1 2%
Dendritic cell sarcoma 1   1 2%
Hemangiopericytoma 1   1 2%
MPNST   1 1 2%
Synovial sarcoma 1   1 2%
Undifferentiated sarcoma 1   1 2%
No diagnosis 1   1 2%